Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration

K Lauper, M Ludici, D Mongin, SA Bergstra, D Choquette, C Codreanu, R Cordtz, D De Cock, L Dreyer, O Elkayam, EM Hauge, D Huschek, KL Hyrich, F Iannone, N Inanc, L Kearsley-Fleet, EK Kristianslund, TK Kvien, BF Leeb, G LukinaDC Nordström, K Pavelka, M Pombo-Suarez, Z Rotar, MJ Santos, A Strangfeld, P Verschueren, DS Courvoisier, A Finckh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1358-1366
Number of pages9
JournalAnnals of the rheumatic diseases
Volume81
Issue number10
DOIs
Publication statusPublished - Oct 2022

Keywords

  • Arthritis
  • Biological Therapy
  • Epidemiology
  • Rheumatoid
  • Therapeutics
  • Tumor Necrosis Factor Inhibitors

Cite this